# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-24-000020
Filing Date
2024-04-25
Accepted
2024-04-24 19:30:39
Documents
24
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | lngd-20240424.htm iXBRL | DEF 14A | 1322349
6 |  | lngd-20240424_g1.gif | GRAPHIC | 9144
7 |  | lngd-20240424_g10.jpg | GRAPHIC | 249614
8 |  | lngd-20240424_g2.jpg | GRAPHIC | 101471
9 |  | lngd-20240424_g3.gif | GRAPHIC | 43730
10 |  | lngd-20240424_g4.gif | GRAPHIC | 11884
11 |  | lngd-20240424_g5.jpg | GRAPHIC | 58200
12 |  | lngd-20240424_g6.jpg | GRAPHIC | 92773
13 |  | lngd-20240424_g7.jpg | GRAPHIC | 83622
14 |  | lngd-20240424_g8.jpg | GRAPHIC | 64104
15 |  | lngd-20240424_g9.jpg | GRAPHIC | 253008
| Complete submission text file | 0000886163-24-000020.txt |  | 4349492

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lngd-20240424.xsd | EX-101.SCH | 2457
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lngd-20240424_def.xml | EX-101.DEF | 2648
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lngd-20240424_lab.xml | EX-101.LAB | 2948
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lngd-20240424_pre.xml | EX-101.PRE | 1719
27 | EXTRACTED XBRL INSTANCE DOCUMENT | lngd-20240424_htm.xml | XML | 92887

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 24872340
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)